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Automating Risk of Bias Assessment
for Clinical Trials
Iain J Marshall, Joe¨l Kuiper and Byron C Wallace
Abstract—Systematic reviews, which summarize the entirety
of the evidence pertaining to a specific clinical question, have
become critical for evidence-based decision making in healthcare.
But such reviews have become increasingly onerous to produce
due to the exponentially expanding biomedical literature base.
This work proposes a step toward mitigating this problem by
automating risk of bias assessment in systematic reviews, in
which reviewers determine whether study results may be affected
by biases (e.g., poor randomization or blinding). Conducting
risk of bias assessment is an important but onerous task. We
thus describe a machine learning approach to automate this
assessment, using the standard Cochrane Risk of Bias Tool which
assesses seven common types of bias. Training such a system
would typically require a large labeled corpus, which would be
prohibitively expensive to collect here. Instead, we use distant
supervision, using data from the Cochrane Database of Systematic
Reviews (a large repository of systematic reviews), to pseudo-
annotate a corpus of 2,200 clinical trial reports in PDF format.
We then develop a joint model which, using the full text of a
clinical trial report as input, predicts the risks of bias while
simultaneously extracting the text fragments supporting these
assessments. This work represents a step toward automating or
semi-automating extraction of data necessary for the synthesis of
clinical trials.
Index Terms—Evidence-based medicine, natural language pro-
cessing, health informatics, machine learning
I. INTRODUCTION AND MOTIVATION
RANDOMIZED controlled trials (RCTs) constitute theprimary literature for evidence-based medicine (EBM).
Systematic reviews of RCTs are considered the strongest form
of evidence because they aim to provide an unbiased view
that incorporates all relevant identified evidence [1]. Flaws in
trial design, conduct, analysis or reporting in the individual
studies comprising a systematic review can result in bias, thus
resulting in treatment effects being over- or under-estimated
[2], [3]. For example, double-blinding—where neither the
participant nor the investigator are aware of which of the
treatments are being administered—has been shown to reduce
bias in trial results [4]. Assessing the risks of important
biases in RCTs is therefore a critical step in interpreting and
synthesizing trial reports.
Such bias assessments inform the analyses conducted in the
systematic review. For example, trials judged to be at high risk
of bias may be withheld in sensitivity analyses, allowing one to
judge treatment efficacy from only the most robust evidence.
This work originally appeared in the proceedings of ACM-BCB 2014.
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Random sequence generation
Allocation concealment
Blinding of participants and personnel
  Blinding of outcome assessment 
Incomplete outcome data 
Selective reporting
Other sources of bias
Welschen 2012 + - - - + ? + + low risk of bias
Soureti 2011 + + - - + + + - high risk of bias
Powers 2011 ? ? - - + + + ? unclear risk of bias
Benner 2008 + - - + + + - Key
Grover 2007 ? + - + + ? +
Maasland 2007 + + - - ? ? +
Steenkiste 2007 + ? - - ? ? +
Sheridan 2006 + + + - + + +
McAlister 2006 + + - + + + +
Fig. 1. Illustrative risk of bias output from the Cochrane tool. Each row
represents a single study. In this work, we aim to automate the generation of
such tables and extract snippets of text from articles to justify each judgement.
Since a single systematic review may contain dozens of RCTs,
and risk of bias assessment requires reading entire articles,
performing such assessments is extremely time-consuming.
Indeed, the time taken to conduct risk of bias assessments has
been identified as a key factor preventing systematic reviews
from being kept up-to-date [5].
As the number of articles describing clinical trials continues
to grow exponentially (in 2010, more than 75 clinical trials
were published daily, on average; the Cochrane Library [6]
alone indexes 286,418 trials as having been conducted in the
last decade [7]), the prospect of manually assessing the risk of
bias for every publication becomes increasingly daunting. And
the time required to complete each review means that they are
often out-of-date [8]. Already the generation of primary evi-
dence is outpacing our ability to synthesize it given pragmatic
resource constraints [9], [10]. The overwhelming volume of
published clinical literature requires the development of new
data mining methods that can automatically process, analyze
and otherwise make sense of clinical trial reports [11], [12].
In this paper (a version of which was originally presented
at ACM-BCB 2014 [13]), we present our automated system
for determining risk of bias from clinical trials, describe
the potential for clinical applications of this technology, and
outline further developments needed to reach this goal. Our
novel contributions in this work are summarized as follows:
• We describe a machine learning approach to automati-
cally judge the risk of bias across clinically important
areas (Figure 1). Automating this quality assessment with
reasonable fidelity may help with myriad evidence-based
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medicine applications.
• We demonstrate that existing systematic reviews may
be used to distantly supervise [14] the annotation of a
corpus of clinical trial reports, thus obviating the need
for expensive manually annotated data.
• We present a novel method for jointly judging the risk
of bias associated with a given article and extracting the
sentence that supports this judgment. This is in keeping
with how humans perform risk of bias assessment. We
demonstrate that this approach improves automated risk
of bias assessment.
II. RELATED WORK
Here we aim to facilitate semi-automated information ex-
traction and summarization from articles describing clinical
trials. It has previously been recognized that machine learning
tools can assist abstract screening [15]–[18], data extraction
[19]–[23], summarization [24], [25], and scoping [26].
To our knowledge, however, there have been fewer efforts to
automate data extraction from articles describing clinical trials
compared to, e.g., work on methods to mine cancer-related and
genetic literature [27], [28]. A particularly relevant example
of the latter is due to Ling et al. [29], [30], in which they
developed automated methods for generating gene summaries
from biomedical literature. Such summaries may be viewed as
semi-structured, as they comprise free-text entries correspond-
ing to several semantic aspects of interest. This is similar to
the present effort, in which we aim to extract sentences that
support judgements concerning the risks of bias across several
domains. To train their gene summarization model, they also
exploited existing resources (as we do here). Specifically,
they generated training data from existing structured gene
summaries in the “FlyBase” database, thus providing plentiful,
if noisy, training data.
In a similar spirit to Ling and colleagues, we leverage
previously curated data to provide indirect supervision to train
our models, thus obviating the need for expensive manual
supervision. In contrast, however, we explicitly have distant
supervision for each domain (or aspect) of interest, whereas
in their case they had to infer the text relevant to each facet
[30]. We note that there is a wealth of work on models for the
general task of information extraction from biomedical texts
[31], but we do not attempt to survey them exhaustively here.
III. DATA USED FOR DISTANT SUPERVISION
A. The Cochrane Database of Systematic Reviews and Risk of
Bias Tool
The Cochrane Collaboration is a global network of re-
searchers who work together to produce systematic reviews. At
present, the group comprises over 30,000 researchers (mostly
physicians and other health practitioners) who have produced
upwards of 5,800 systematic reviews,1 collectively published
as the Cochrane Database of Systematic Reviews (CDSR) [6].
This database contains structured data manually extracted from
the papers describing the included trials.
1http://www.cochrane.org/cochrane-reviews/
cochrane-database-systematic-reviews-numbers
Allocation concealment
Low risk
Quote: "The Family Practice Research 
Coordinator at the University of British 
Columbia held this sequence independently 
and remotely"
Bias
Authors judgement
Support for judgement
Fig. 2. Review authors’ justification for their score of an example study
in the Allocation concealment domain. Here the risk of bias was deemed
low and the highlighted quote was extracted (into the CDSR) as support
for this judgement. To train machine learning models that can automate this
bias assessment (and supporting sentence extraction), we match entries in the
CDSR to full-text articles that describe the corresponding clinical trials, and
we identify the extracted sentences stored in the CDSR for said trials within
these matched full-texts. This process will necessarily be noisy, i.e., introduce
false positives and false negatives into the training data, but we show that it
is precise enough to train reasonably accurate classifiers.
The Cochrane Collaboration has developed a tool for assess-
ing bias in clinical trials. The tool has been adopted across all
Cochrane systematic reviews since 2008 [2]. Additionally, the
tool is now widely used outside of Cochrane [32]. The tool
comprises seven domains by default (see Table I), but domains
may be added or removed by authors based on the needs of
their specific review.
Review authors judge the risk of bias in each domain as
high, low, or unknown (see Figure 1). In this paper we focus
on the first six domains, which are used consistently across
reviews; the seventh domain covers “other” risks, and therefore
varies greatly according to the needs of individual studies.
For many assessments, Cochrane reviewers justify their risk
of bias assessments by quoting supporting text directly from
the original study (see Figure 2). This is desirable because it
increases the transparency of the judgments. Here we exploit
these manually extracted sentences as ‘distant’ supervision
with which to train our models. The benefit of this approach
is that rather than acquiring expensive labels from domain
experts, we are leveraging an existing corpus.
B. Data
In this work we use descriptions of, and data about, clinical
trials manually extracted by Cochrane reviewers for previously
conducted systematic reviews (i.e., those in the CDSR). We
use this structured data as a substitute for manual annotations.
In this sense the strategy we take here is distantly supervised
[14], [33].
1) Data structure of Cochrane reviews: The CDSR contains
structured and semi-structured data for the individual studies
comprising each systematic review. Each review contains a
wealth of (structured) data about the included clinical trials
included in the review and there are usually multiple clinical
trials described in each review. Cochrane reviews use basic
clinical trial identifiers that are unique per review (based on
the first author surname and year of publication) throughout
these files. It is therefore possible to extract structured data and
semi-structured data (i.e., filtered snippets of text) that describe
a specific clinical trial. Using these identifiers, we were able
to obtain full structured citation data for the primary reference
of all included studies across the entire CDSR.
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Domain title Explanation
Random sequence generation Was the method of randomization scientifically valid
Allocation concealment Are researchers able to influence which groups participants are allo-
cated to
Blinding of participants and personnel Were participants treatment groups concealed from them and study
personnel
Blinding of outcome assessment Was the person assessing outcomes blinded to the participants’ treat-
ment group
Incomplete outcome data Might an imbalance in study withdrawals or dropouts lead to a bias
in results
Selective reporting Have any outcomes studied not been published (usually by comparison
with a protocol)
Other sources of bias
TABLE I
POSSIBLE SOURCES OF BIAS ASSESSED BY THE RISK OF BIAS TOOL.
Domain Documents at low risk of bias (%) Sentences relevant to risk of bias (%)
Random sequence generation 1,163/2,088 (55.7%) 1,396/565,134 (0.3%)
Allocation concealment 936/2,182 (42.9%) 887/593,018 (0.2%)
Blinding of participants and personnel 981/2,078 (47.2%) 1052/565,827 (0.2%)
Blinding of outcome assessment 363/714 (50.8%) 336/196,222 (0.2%)
Incomplete outcome data 1,306/2,081 (62.8%) 641/564,132 (0.1%)
Selective reporting 1,105/1,855 (59.6%) 83/500,006 (<0.1%)
TABLE II
DESCRIPTION OF BASELINE LABEL FREQUENCIES IN THE TEST DATA; DENOMINATORS REPRESENT THE NUMBER OF DOCUMENTS OR SENTENCES WHICH
WERE ABLE TO BE LABELLED (POSITIVELY OR NEGATIVELY) FOR EACH DOMAIN.
2) Linking to full text studies: To facilitate retrieving the
original trial reports, we linked the trials to PubMed, a popular
portal to biomedical study citations. To handle transcription
errors by Cochrane review authors, we used non-overlapping
combinations of the citation elements to form multiple search
queries. Each of the queries might be expected to uniquely
retrieve the target paper; we assumed an accurate match in
cases where two or more independent queries retrieved the
same article. Using this strategy, we linked the semi-structured
descriptions of 52,454 clinical trials from Cochrane reviews to
their unique PubMed identifiers, which allowed us to access
citation information for these articles.
3) Justification for risk of bias assessments: The risk of
bias classification (high, low, or unknown) is structured and
retrievable per clinical trial for individual domains. The risk of
bias tool allows much flexibility: review authors may remove
core domains or add new domains depending on the needs of
their review. For this reason, we restricted our task to the core
default domains which have wide uptake.
The risk of bias tool requires review authors to record an
explanation for each risk of bias judgment. This explanation
is recorded as unstructured text, but is retrievable per study. It
is permissible to use a quote from the original trial report to
justify a decision, and many review authors have informally
adopted a standardized way of recording this (see Figure 2).
We exploited this convention by searching for this pattern
throughout the CDSR using a regular expression. With this
approach we identified supporting quotes in at least one
domain for a total of 3,529 unique clinical trials. For 2,200 of
these trials, we were able to obtain full text original reports
in PDF format. These PDFs linked with the structured and
unstructured descriptions of the same trials from the CDSR
formed our corpus.
4) Aligning Cochrane data with original trial reports:
PDFs of clinical trial reports were converted to plain text using
the pdftotext utility from Xpdf.2 We retrieved individual
quotes from the Cochrane database, and sought a matching
string in the clinical trial report. For the sentence identifica-
tion task, the clinical trial reports were word and sentence
tokenized; sentences that matched a quote were labeled as
‘positives’. All others were labeled as ‘negatives’. For the
document classification task, we labeled each full text trial
report as being at high, low, or unknown risk of bias using
the classification from the linked review (these labels are
explicitly available in the CDSR). Approximately half of the
trials included were judged to be at low risk of bias for each
domain, whereas <1% of sentences were relevant to bias in
any domain (see Table II).
IV. MACHINE LEARNING METHODS
In this section we introduce a baseline approach which
independently learns risk of bias assessment and supporting
sentence extraction. We then introduce a joint model that
leverages both document level risk of bias assessments and
the associated supporting quotes. The intuition here is that the
identified sentences will inform the document level predictions
and thus result in improved predictive performance.
A. Overall Risk of Bias Prediction
We first consider the task of predicting the study-level risk
of bias from the full-text of articles. As an initial approach,
we treat this as a standard binary classification task, where the
(binary) output space Y comprises low risk and unknown/high
risk. This dichotomization of the task is practical, since
reviewers will typically conduct additional sensitivity analyses
using only studies at low risk to investigate the robustness of
their results.
We use the soft-margin Support Vector Machine (SVM)
[34] as our classification model. We will denote each article
2http://www.foolabs.com/xpdf/
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by xi, its label for quality domain q ∈ Q (where Q is the
set of quality domains enumerated in Table I) by yqi and a
feature extracting function by φ. For the latter we use standard
(unigram) bag-of-words text encoding. To map the problem
into a binary task, we define a function F as follows:
F(yqi ) =
{
1 if yqi = low risk of bias
−1 otherwise (1)
Then, for each quality domain q we find a minimizing weight
vector wqd (the d here is to distinguish this vector from those
introduced for the sentence extraction task, below). We assume
risk of bias labels assume the form:
yqi = sign{wqdφ(xi)} (2)
And we find each wqd by solving the following objective:
argmin
wqd
α‖wqd‖2 +
nq∑
i=1
L(sign{wqdφ(xi)},F(yqi )) (3)
Where nq denotes the number of labeled instances for the
domain q and L is the usual hinge-loss function. The α
parameter controls the degree of regularization: we tune this
via grid-search over training data, maximizing for F1 score.
B. Sentence identification
We take a similar approach for identifying sentences as for
the overall document-level judgments described above, though
here labels indicate whether a given sentence was selected by a
domain expert as supporting her judgment. Denoting sentence
j in document i by sij and its associated label (for target
domain q) by lqij , we posit the classification model:
lqij = sign{wqsφ(sij)} (4)
And we estimate the associated sentence extraction param-
eters wqs by optimizing the following (separately for each
domain):
argmin
wqs
α‖wqs‖2 +
nq∑
i=1
mi∑
j=1
L(sign{wqsφ(sij)}, lqij)) (5)
where the notation is similar to above (Equation 3) with the
addition of mi, which we used to denote the number of
sentences in document i. Note that we use the same feature
extraction function φ as we did for the full-text predictions
(here this extracts binary bag of words features).
V. A JOINT RISK OF BIAS AND SUPPORTING SENTENCE
EXTRACTION MODEL
We now introduce a novel model that integrates the sentence
extraction task with document level risk of bias prediction. A
joint model is preferable to independent models for classifica-
tion and extraction since the sentences identified as describing
bias ought to inform the overall risk of bias assessment.
Intuitively, if the text describing random sequence generation
contains words such as computer and generated, we would
expect the document to be classified as being at low risk of
bias for this domain (see Table III).
A. Informing Overall Risk of Bias Prediction with Supporting
Sentences
To realize a joint model, we introduce terms into the
document level risk of bias prediction that interact n-gram
indicator features with supporting sentence predictions. We
will again denote the binary prediction regarding whether
sentence j in article i (sentence sij) supports the risk of bias
judgment for domain q by lqij (we assume this is 0 or 1) and
we will denote the corresponding predictions by lˆqij . Further,
we denote the supporting sentence for domain q in document
i by sqi∗.
We then augment the baseline risk of bias model (Equation
3) as follows:
yqi = sign{wqyφ(xi) +wqy,sλy(sqi∗)} (6)
Here λy is a feature extraction function for supporting sen-
tences: this can be viewed as adding terms that indicate tokens
(unigrams) being present in a supporting sentence within a
document. Put another way, these are interaction terms that
cross bag-of-words features with their presence in judgment-
supporting sentences. We use wqy,s to denote the weight vector
associated with the sentence interaction features for domain q.
During training we minimize over w′y = w
q
y +w
q
y,s (here +
denotes vector concatenation).
For unlabeled documents at test time, we will not know
which sentence supports quality assessment (i.e., which is sqi∗).
Instead, we rely on predicted sentence labels, lˆqij . In particular,
for each quality domain q we predict for each sentence j in
article i whether it supports the judgment for said domain.
If the prediction is that it does, we add interaction terms
accordingly. Note that at test time, we may therefore add
interaction features from multiple sentences that are predicted
as supporting quality assessment in a given article (because
these predictions are made independently). We can write the
whole predictive model out as follows:
yqi = sign{wqyφ(xi) + lˆqi0wqy,sλy(sqi0)+
...+ lˆqimiw
q
y,sλy(s
q
imi
)} (7)
Where the lˆqij are predictions made via Equation 4.
VI. EMPIRICAL RESULTS
We matched the full-texts of 2,200 clinical trial reports to
semi-structured descriptions of the same trials in the CDSR.
We first consider the task of identifying studies with low risk
of bias (or other). We show five-fold cross-validation results
for this task in Tables III and IV; and report precision, recall
and F1 with respect to low risk of bias (or not). Precision
is the fraction of studies classified as low risk that indeed
were (as per the Cochrane reviewer’s decision); recall is the
total fraction of low risk studies correctly identified as such,
and F1 is their harmonic mean. Performance for the sentence
identification task is shown in Table V. As can be seen
in Figure VI, the joint model (where sentence predictions
informed the overall document judgment) improved the pre-
dictions across all domains. And as can be seen in Table IV,
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Domain F1 precision recall most informative features
Random sequence generation 0.70 (0.64, 0.79) 0.67 (0.51, 0.82) 0.79 (0.52, 0.93) computer, generated, random, randomiza-
tion
Allocation concealment 0.68 (0.65, 0.72) 0.66 (0.60, 0.71) 0.72 (0.57, 0.82) sealed, generated, envelopes, randomization
Blinding of participants and per-
sonnel
0.57 (0.38, 0.69) 0.66 (0.62, 0.69) 0.53 (0.26, 0.78) blind, placebo, double, influence, summary
Blinding of outcome assessment 0.62 (0.54, 0.67) 0.52 (0.46, 0.56) 0.81 (0.69, 1.00) blinded, secondary, nd, session, responsible
Incomplete outcome data 0.75 (0.73, 0.77) 0.63 (0.61, 0.70) 0.93 (0.82, 0.99) immediately, aimed, id, compare, intra-
venous
Selective reporting 0.69 (0.57, 0.78) 0.62 (0.59, 0.71) 0.82 (0.48, 0.98) march, finding, maintenance, institute, july
TABLE III
DOCUMENT CLASSIFICATION RESULTS: BASELINE MODEL (SECTION IV-A) PERFORMANCE. SHOWN ARE AVERAGES OVER FIVE-FOLD
CROSS-VALIDATION (AND RANGES). WE ALSO INCLUDE THE FOUR MOST INFORMATIVE FEATURES ACCORDING THE MODEL FOR ILLUSTRATIVE
PURPOSES.
Domain F1 precision recall most informative features
Random sequence generation 0.72 (0.67, 0.80) 0.69 (0.52, 0.83) 0.78 (0.63, 0.94) computer−i, computer, generated−i,
random−i
Allocation concealment 0.70 (0.68, 0.75) 0.67 (0.55, 0.79) 0.77 (0.59, 0.88) by−i, the−i, was−i, and−i, sealed,
calculated
Blinding of participants and per-
sonnel
0.66 (0.59, 0.71) 0.65 (0.60, 0.73) 0.70 (0.50, 0.84) blind, double, placebo, placebo−i,
double−i, blind−i
Blinding of outcome assessment 0.67 (0.63, 0.69) 0.53 (0.46, 0.57) 0.92 (0.85, 1.00) established, were−i, single, generated,
blinded
Incomplete outcome data 0.76 (0.74, 0.79) 0.64 (0.61, 0.71) 0.94 (0.89, 1.00) aimed, described, needed, wong, model,
second
Selective reporting 0.72 (0.70, 0.78) 0.63 (0.59, 0.71) 0.87 (0.71, 0.98) oral, issue, unrelated, march, mainte-
nance
TABLE IV
DOCUMENT CLASSIFICATION RESULTS: JOINT MODEL (SECTION V-A) PERFORMANCE. −i REPRESENTS THE DESCRIBED ‘INTERACTION’ FEATURES,
WHERE THE TOKEN OCCURS IN A SENTENCE DEEMED TO BE RELEVANT TO THE BIAS DOMAIN.
0.65
0.70
0.75
0.80
random sequence generation
0.66
0.68
0.70
0.72
0.74
allocation concealment
0.40
0.45
0.50
0.55
0.60
0.65
0.70
participant/personnel blinding
baseline joint model
0.40
0.45
0.50
0.55
0.60
0.65
0.70
F1
blinding to outcomes
0.73
0.74
0.75
0.76
0.77
0.78
0.79
incomplete outcome reporting
0.60
0.65
0.70
0.75
selective outcome reporting
Fig. 3. Results from five-fold cross-validation across the 6 domains. The y-
axis is F1 score. Lines connect results achieved on the same folds; the thick
black lines are means (the grey lines correspond to individual fold results).
The proposed joint model consistently outperforms the baseline approach.
interaction features comprised the majority of the top-ranking
(most informative) features. Thus, the proposed strategy of
incorporating features extracted from sentences deemed likely
to support risk of bias assessments improves classification
performance.
VII. DISCUSSION
We demonstrated that systematic reviews may be used to
“distantly supervise” the training of biomedical text extraction
systems, thus obviating the need for expensive manual anno-
tation. In particular, we have shown the feasibility of this ap-
proach for training models to perform risk of bias assessment
for articles describing clinical trials. We have also described
a joint model for this task that simultaneously identifies the
Domain Performance
F1 precision recall
Random sequence generation 0.53 0.43 0.68
Allocation concealment 0.48 0.42 0.58
Blinding of participants and personnel 0.37 0.30 0.50
Blinding of outcome assessment 0.38 0.34 0.42
Incomplete outcome data 0.23 0.16 0.44
Selective reporting 0.06 0.11 0.04
TABLE V
RESULTS FOR AUTOMATING THE SENTENCE IDENTIFICATION TASK (USING
A STANDARD BOW AND REGULARIZED LINEAR MODEL APPROACH).
text fragments justifying the assessment and demonstrated
that this novel approach improves document-level risk of bias
assessment performance. Because the Cochrane risk of bias
tool requires authors to transparently describe the reasons
for their decisions, an automated tool would therefore have
to justify its decisions. The method presented here has the
advantage of being able to provide the sentence from the trial
report which led to the classification.
But, assessing the risk of bias in a study is inherently
subjective. A validation study of the Cochrane risk of bias tool
found wide variations in judgments by different researchers in
all domains, with the selective reporting domain showing the
least agreement (κ=0.13, 95% CI –0.05 to 0.31) [35]. The
instructions for the risk of bias tool indicate that ‘convincing
text’ from the original clinical trial reports is uncommon,
and recommends consulting the trial protocol where possible.
Our model was not able to predict sentences with any useful
accuracy in this domain, though we do not think this is
surprising given the difficulty (as evidenced by the poor
agreement between domain experts).
Concerning the sentence identification task, we used quota-
tions from Cochrane as training and test data. But we note
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that when assessing the risk of bias, authors select what
they deem to be the single best sentence as evidence. This
means other, equally relevant supporting sentences, may not
be marked by experts as such, thus resulting in false negatives.
Ideally the test data would identify all relevant sentences as
evidence. These issues imply that the results reported here may
be pessimistic for this task. And, this offers an interesting
perspective to the evaluation of our method: as the data is
inherently noisy expert evaluation of our produced results
might yield very different performance. We are currently
conducting a ‘deployed’ evaluation of these models which
aims to shed light on such issues. To this end, we have
recruited experienced systematic review authors, who will
manually assess the quality of output from the tool. We plan to
conduct a blinded comparison of model output versus human
authored text and bias judgements relating to the same trials
taken from published systematic reviews. This will allow us
to empirically address whether automated methods provide
accuracy comparable to human experts.
To further improve the performance of our system, related
methods developed for sentiment analysis [36], [37] could
be explored, as the task is conceptually similar. We are
particularly interested in exploring probabilistic models that
aim to jointly model sentiment and text fragments [38], [39].
We also note that a shortcoming of the proposed sentence
extraction model is that the model for each domain (i.e.,
each weight vector wqs) is fit independently of those for other
domains. Going forward we hope to extend this model to take
a multi-task approach, i.e., jointly fit a single model over all
domains [40], which could improve predictive performance
further. Additional features, like journal impact factor, date of
publication, or ontology terms derived from text, might also
further improve performance.
Finally, the proposed distantly supervised method has the
potential to be extended to extract other variables of interest
from clinical trial reports. Specifically, the CDSR contains
(semi-)structured information on trial populations, interven-
tions, outcomes, and results data. Other structured resources,
e.g. SRDR3 and ClinicalTrials.gov4 contain highly-structured
data on additional variables. Tools to automate these tasks
could lead to a large reduction in the time required to produce
systematic reviews.
In practice, we envision a hybrid computer-human system in
which machine learning models guide the extraction process
(thereby reducing manual labor). This necessitates the devel-
opment of a tool to integrate the machine learning machinery
described here with an intuitive graphical user interface. We
have already built a prototype tool for risk of bias assessment
[42].5 We hope to pair this tool with our semi-automated
abstract screening software [43]. This will further optimize
reviewer workflow by enabling prioritized abstract screening
coupled with semi-automated data extraction from relevant lit-
erature. Another option to optimize reviewer workflow would
be to use the computer generated extractions for redundancy
3the Systematic Review Data Repository [41] http://srdr.ahrq.gov/
4the US regulatory database for clinical trial regsistrations https://
clinicaltrials.gov/
5available at: https://robot-reviewer.vortext.systems
to improve data quality; i.e., rather than having two experts
independently extract data, we might substitute the computer
for one of them. However, as automated annotation becomes
more wide-spread, questions about scalability and data prove-
nance become relevant [44]. To address these questions we
envision an integrated system that borrows from semantic web
technology such as Open Annotations6 and W3C Prov7. Such
a system should ensure that one can trace the annotations
and extractions back to their source documents, and to their
authors, at any time.
We conclude that clinicians and health sciences researchers
are overwhelmed with data. And, if we are to maintain
the rigor and comprehensiveness of evidence-based medicine
products, new data mining methods are sorely needed to
mitigate problems of information overload. This work is a
step toward such larger aims.
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